These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32502649)

  • 21. Physicians' Awareness and Utilization of Genetic Services in Texas.
    Diamonstein C; Stevens B; Shahrukh Hashmi S; Refuerzo J; Sullivan C; Hoskovec J
    J Genet Couns; 2018 Aug; 27(4):968-977. PubMed ID: 29280038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct-to-Consumer Genetic Testing: Value and Risk.
    Majumder MA; Guerrini CJ; McGuire AL
    Annu Rev Med; 2021 Jan; 72():151-166. PubMed ID: 32735764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergency department referral patterns of Australian general practitioner registrars: a cross-sectional analysis of prevalence, nature and associations.
    Catzikiris N; Tapley A; Morgan S; van Driel M; Spike N; Holliday EG; Ball J; Henderson K; McArthur L; Magin P
    Aust Health Rev; 2019 Feb; 43(1):21-28. PubMed ID: 29117892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct to consumer genetic testing: a systematic review of position statements, policies and recommendations.
    Skirton H; Goldsmith L; Jackson L; O'Connor A
    Clin Genet; 2012 Sep; 82(3):210-8. PubMed ID: 22372614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of genetic counsellors in genomic testing triage: Outcomes of a genomic consultation service in British Columbia, Canada.
    Cook CB; Dragojlovic N; Siemens A; Adam S; du Souich C; van Karnebeek C; Lehman A; Nelson TN; Friedman J; ; ; Lynd LD; Elliott AM
    Eur J Med Genet; 2021 Jul; 64(7):104024. PubMed ID: 32798762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using behaviour change and implementation science to address low referral rates in oncology.
    Long JC; Debono D; Williams R; Salisbury E; O'Neill S; Eykman E; Butler J; Rawson R; Phan-Thien KC; Thompson SR; Braithwaite J; Chin M; Taylor N
    BMC Health Serv Res; 2018 Nov; 18(1):904. PubMed ID: 30486812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Retrospective Exploration of the Impact of the 'Angelina Jolie Effect' on the Single State-Wide Familial Cancer Program in Perth, Western Australia.
    Freedman R; Mountain H; Karina D; Schofield L
    J Genet Couns; 2017 Feb; 26(1):52-62. PubMed ID: 27265404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Direct-to-Consumer Genetic Testing Policy in Korea Based on Consumer Preference.
    Jeong G
    Public Health Genomics; 2017; 20(3):166-173. PubMed ID: 28817817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct-to-consumer raw genetic data and third-party interpretation services: more burden than bargain?
    Moscarello T; Murray B; Reuter CM; Demo E
    Genet Med; 2019 Mar; 21(3):539-541. PubMed ID: 29997392
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment.
    Mouchawar J; Hensley-Alford S; Laurion S; Ellis J; Kulchak-Rahm A; Finucane ML; Meenan R; Axell L; Pollack R; Ritzwoller D
    Genet Med; 2005 Mar; 7(3):191-7. PubMed ID: 15775755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Direct-to-Consumer Genetic Testing on Patient and Provider.
    Dinulos MBP; Vallee SE
    Clin Lab Med; 2020 Mar; 40(1):61-67. PubMed ID: 32008640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consumer Perspectives on Access to Direct-to-Consumer Genetic Testing: Role of Demographic Factors and the Testing Experience.
    Gollust SE; Gray SW; Carere DA; Koenig BA; Lehmann LS; McGUIRE AL; Sharp RR; Spector-Bagdady K; Wang NA; Green RC; Roberts JS;
    Milbank Q; 2017 Jun; 95(2):291-318. PubMed ID: 28589610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should You Recommend Direct-to-Consumer Genetic Testing for This Patient? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Smetana GW; Vassy JL; Hofstatter E; Libman H
    Ann Intern Med; 2020 Oct; 173(7):563-571. PubMed ID: 33017547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Who's on third? Regulation of third-party genetic interpretation services.
    Guerrini CJ; Wagner JK; Nelson SC; Javitt GH; McGuire AL
    Genet Med; 2020 Jan; 22(1):4-11. PubMed ID: 31402353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer genetics program: Follow-up on clinical genetics and genomic medicine in Qatar.
    Al-Bader SB; Alsulaiman R; Bugrein H; Ben Omran T; Abbaszadeh F; Bakheet N; Apsa Kusasi S; Abdou N; Solomon BD; Ghazouani H
    Mol Genet Genomic Med; 2018 Nov; 6(6):865-872. PubMed ID: 30556325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lessons Learned from Direct-to-Consumer Genetic Testing.
    Petersen LM; Lefferts JA
    Clin Lab Med; 2020 Mar; 40(1):83-92. PubMed ID: 32008642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limitations of direct-to-consumer genetic testing for age-related macular degeneration.
    Shaheen AR; Uhr JH; Sridhar J; Yannuzzi NA
    Eur J Ophthalmol; 2023 Nov; 33(6):2059-2061. PubMed ID: 37211635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health orientation and individual tendencies of a sample of Italian genetic testing consumers.
    Oliveri S; Durosini I; Cutica I; Cincidda C; Spinella F; Baldi M; Gorini A; Pravettoni G
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1291. PubMed ID: 32500972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of comprehensive oncogenetics training interventions for general practitioners, evaluated at multiple performance levels.
    Houwink EJ; Muijtjens AM; van Teeffelen SR; Henneman L; Rethans JJ; Jacobi F; van der Jagt L; Stirbu I; van Luijk SJ; Stumpel CT; Meijers-Heijboer HE; van der Vleuten C; Cornel MC; Dinant GJ
    PLoS One; 2015; 10(4):e0122648. PubMed ID: 25837634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer genetics service provision: a comparison of seven European centres.
    Hopwood P; van Asperen CJ; Borreani G; Bourret P; Decruyenaere M; Dishon S; Eisinger F; Evans DG; Evers-Kiebooms G; Gangeri L; Hagoel L; Legius E; Nippert I; Rennert G; Schlegelberger B; Sevilla C; Sobol H; Tibben A; Welkenhuysen M; Julian-Reynier C
    Community Genet; 2003; 6(4):192-205. PubMed ID: 15331865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.